Journey Medical Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Journey Medical does not have a record of paying a dividend.
Wichtige Informationen
n/a
Dividendenausschüttung
-4.9%
Rückkaufsrendite
| Gesamte Aktionärsrendite | -4.9% |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Ausschüttungsquote | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth
Oct 03
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden
Sep 14Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?
May 06Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%
Mar 11Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues
Jan 18Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Nov 10US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results
May 12Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if DERM's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if DERM's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Journey Medical Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (DERM) | n/a |
| Untere 25 % des Marktes (US) | 1.5% |
| Markt Top 25 % (US) | 4.5% |
| Branchendurchschnitt (Pharmaceuticals) | 2.3% |
| Analystenprognose (DERM) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: Unable to evaluate DERM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate DERM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate DERM's payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as DERM has not reported any payouts.